Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Davis

Showing results (111-120 of 400) with videos related to

Pageof 40
Sort By:
European Journal of Pharmacology|April 23, 1982
Dopamine autoreceptor and postsynaptic receptor blocking potency of neurolepticsK S Kendler, H S Bracha, K L Davis
The American Journal of Psychiatry|December 1, 1979
Choline chloride in schizophreniaK L Davis, L E Hollister, P A Berger
Communications in Psychopharmacology|January 1, 1980
Apomorphine in schizophreniaL E Hollister, K L Davis, P A Berger
Psychopharmacology Communications|January 1, 1975
Butaclamol hydrochloride in newly admitted schizophrenicsL E Hollister, K L Davis, P A Berger
The New England Journal of Medicine|October 25, 1979
Enhancement of memory by physostigmineK L Davis, R C Mohs, J R Tinklenberg
Biological Psychiatry|December 15, 1990
Glycinamide ribonucleotide synthetase activity in lymphocytes from patients with Alzheimer's disease and normal controlsZ Zemishlany, D Patterson, K L Davis, et al.
The American Journal of Psychiatry|April 1, 1981
Lithium's effect of parathyroid hormoneB M Davis, A Pfefferbaum, S Krutzik, et al.
The American Journal of Psychiatry|December 1, 1974
Letter: EEGs of "binge" eatersK L Davis, B Qualls, L Hollister, et al.
Schizophrenia Research|June 1, 2005
Variations in differential gene expression patterns across multiple brain regions in schizophreniaP Katsel, K L Davis, J M Gorman, et al.
The American Journal of Psychiatry|November 1, 1991
Dopamine in schizophrenia: a review and reconceptualizationK L Davis, R S Kahn, G Ko, et al.
Pageof 40

Showing results (111-120 of 400) with videos related to

Sort By:
Pageof 40
European Journal of Pharmacology|April 23, 1982
Dopamine autoreceptor and postsynaptic receptor blocking potency of neurolepticsK S Kendler, H S Bracha, K L Davis
The American Journal of Psychiatry|December 1, 1979
Choline chloride in schizophreniaK L Davis, L E Hollister, P A Berger
Communications in Psychopharmacology|January 1, 1980
Apomorphine in schizophreniaL E Hollister, K L Davis, P A Berger
Psychopharmacology Communications|January 1, 1975
Butaclamol hydrochloride in newly admitted schizophrenicsL E Hollister, K L Davis, P A Berger
The New England Journal of Medicine|October 25, 1979
Enhancement of memory by physostigmineK L Davis, R C Mohs, J R Tinklenberg
Biological Psychiatry|December 15, 1990
Glycinamide ribonucleotide synthetase activity in lymphocytes from patients with Alzheimer's disease and normal controlsZ Zemishlany, D Patterson, K L Davis, et al.
The American Journal of Psychiatry|April 1, 1981
Lithium's effect of parathyroid hormoneB M Davis, A Pfefferbaum, S Krutzik, et al.
The American Journal of Psychiatry|December 1, 1974
Letter: EEGs of "binge" eatersK L Davis, B Qualls, L Hollister, et al.
Schizophrenia Research|June 1, 2005
Variations in differential gene expression patterns across multiple brain regions in schizophreniaP Katsel, K L Davis, J M Gorman, et al.
The American Journal of Psychiatry|November 1, 1991
Dopamine in schizophrenia: a review and reconceptualizationK L Davis, R S Kahn, G Ko, et al.
Pageof 40